The safe interval time of cold bloody cardioplegic solution transfusion during CABG
ثبت نشده
چکیده
Background: During CABG cardioplefic solution is used for cardiac arrest and myocardial protection but there is no defined safety interval time for cardioplegia infusion. Measuremen of the metabolite release from myocardial cells in coronary sinus implicateis accurate protective effect and safety interval of cardioplegia Materials and Methods: Thirteen patients that were scaduled for CABG cold blood cardioplegia transfused via aortic root. Coronary sinus blood samples were taken before and after cross clamping of the aorta at the times of 7, 14 and 20 minutes. The samples were analyzed for pH and lactate immediately. Results: The pH and lactate concentration in coronary at the time of 15 minute after the second dose of transfusion of blood cardioplegia were out of the range of acceptable level (pH=7.22±0.047 lactate=21±2.859mg/dl ρ=0.02). Conclusion: This study indicates that safe interval time between the first and second dose of cardioplegia transfusion was 20 minute and the between second and third dose was 15 minutes.
منابع مشابه
The safe interval time of crystalloid cardioplegic solution transfusion during CABG
Background: Cold crystalloid cardioplegic solution is used for cardiac arrest and myocardial protection during CABG intermittently. There is no defined safety interval time for cardioplegia infusion. Measuremen of the metabolite release from myocardial cells in coronary sinus implicateis accurate protective effect and safety interval of cardioplegia. There is no study that surveys the metabolit...
متن کاملThe Cardioprotective Effects of N acetylcysteine as an Additive to the Blood Cardioplegia During Coronary Artery Bypass Grafting
Introduction: During coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass (CPB), the role of cardioplegic solution which results in cardiac arrest, is critical. This study was planned to evaluate the clinical impacts of N acetylcysteine (NAC) enriched cold-blood cardioplegia on early reperfusion injury in patients with ischaemic heart disease undergoing CABG Methods: In a...
متن کاملCardioplexol, a new cardioplegic solution for elective CABG
Background Cardioplexol (Swiss Cardio Technologies) is a hyperkalemic, low-dose, single-shot cardioplegic solution which offers immediate asystole of the heart, maintenance up to 90 minutes and immediate reversal of asystole after release of cross clamp. Intermittent crossclamping with Lidoflazine is the current operative technique used in our center. Main question was whether Cardioplexol is a...
متن کاملAssociated factors with survivals in patients undergoing orthotopic heart transplant using retrograde blood microcardioplegia.
BACKGROUND Several techniques and cardioplegic solutions have been used for heart preservation during transplant procedures. Unfortunately, there is a lack of ideal method for myocardial preservation in the clinical practice. The use of retrograde cardioplegia provides continuous infusion of cardioplegic solution during the graft implantation. This strategy may provide better initial recovery o...
متن کاملHistidine-tryptophan-ketoglutarate solution decreases mortality and morbidity in high-risk patients with severe pulmonary arterial hypertension associated with complex congenital heart disease: an 11-year experience from a single institution
Cardioplegic reperfusion during a long term ischemic period interrupts cardiac surgery and also increases cellular edema due to repeated solution administration. We reviewed the clinical experiences on myocardial protection of a single perfusion with histidine-tryptophan-ketoglutarate (HTK) for high-risk patients with severe pulmonary arterial hypertension associated with complex congenital hea...
متن کامل